Sudeep Pharma

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE0QPI01025
  • NSEID: SUDEEPPHRM
  • BSEID: 544619
INR
1,053.85
95.8 (10.0%)
BSENSE

Aug 10

BSE+NSE Vol: 9.47 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

9.47 lacs (23.45%) Volume

Shareholding (Jun 2026)

FII

1.81%

Held by 17 FIIs

DII

15.65%

Held by 18 DIIs

Promoter

76.15%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Dashboard
1

Poor long term growth as Net Sales has grown by an annual rate of 0% and Operating profit at 0% over the last 5 years

 
2

Positive results in Mar 26

3

With ROE of 19.6, it has a Very Expensive valuation with a 8.9 Price to Book Value

 
4

Majority shareholders : Promoters

 
stock-summaryMojo Parameters
Mojo Parameters
Loading Valuation Snapshot...
Stock DNA
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

INR 11,419 Cr ()

stock-summary
P/E

65.00

stock-summary
Industry P/E

37

stock-summary
Dividend Yield

0.16%

stock-summary
Debt Equity

0.00

stock-summary
Return on Equity

0.00%

stock-summary
Price to Book

12.25

Revenue and Profits:
Net Sales:
158 Cr
(Quarterly Results - Jun 2026)
Net Profit:
41 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0.16%)
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
59.69%
0%
59.69%
6 Months
58.9%
0%
58.9%
1 Year
0%
0%
0.0%
2 Years
0%
0%
0.0%
3 Years
0%
0%
0.0%
4 Years
0%
0%
0.0%
5 Years
0%
0%
0.0%

Sudeep Pharma for the last several years.

Risk Adjusted Returns v/s stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryNews & Corporate Actions
News
Icon
No Recent News for the Company
Announcements stock-summary

General Update

06-Aug-2026 | Source : BSE

General Update

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

05-Aug-2026 | Source : BSE

Submission of Audio Recording of Earnings Call held on 05.08.2026

Shareholder Meeting / Postal Ballot-Scrutinizers Report

05-Aug-2026 | Source : BSE

Submission of E-voting and Scrutinizers Report for the 37th Annual General Meeting held on 04.08.2026

Corporate Actions stock-summary
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

Sudeep Pharma Ltd has declared 150% dividend, ex-date: 23 Jul 26

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available

stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
0
EBIT Growth (5y)
0
EBIT to Interest (avg)
33.98
Debt to EBITDA (avg)
0.72
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0.65
Tax Ratio
23.58%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
17.46%
ROCE (avg)
24.88%
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
65
Industry P/E
37
Price to Book Value
13.48
EV to EBIT
57.65
EV to EBITDA
53.80
EV to Capital Employed
12.99
EV to Sales
18.59
PEG Ratio
NA
Dividend Yield
0.14%
ROCE (Latest)
22.53%
ROE (Latest)
19.57%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bullish
RSI
No Signal
Bollinger Bands
Bullish
KST
Dow Theory
Bullish
Bullish
OBV
No Trend
Mildly Bullish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Jun 2026stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 14 Schemes (5.47%)

FIIs

Held by 17 FIIs (1.81%)

Promoter with highest holding

Riva Resources Private Limited (40.35%)

Highest Public shareholder

Nuvama Crossover Opportunities Fund - Series Iii (2.95%)

Individual Investors Holdings

4.89%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Standalone) - Jun'26 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Jun 2026 is 31.82% vs -11.20% in Mar 2026",
        "dir": 1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "QoQ Growth in quarter ended Jun 2026 is 31.28% vs -4.09% in Mar 2026",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Jun'26",
        "Mar'26",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "105.68",
          "val2": "80.17",
          "chgp": "31.82%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "39.19",
          "val2": "28.89",
          "chgp": "35.65%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "1.76",
          "val2": "1.97",
          "chgp": "-10.66%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "33.83",
          "val2": "25.77",
          "chgp": "31.28%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "37.08%",
          "val2": "36.04%",
          "chgp": "1.04%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "alert": "No Half Yearly Results declared by Sudeep Pharma"
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "alert": "No Nine Monthly Results declared by Sudeep Pharma"
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Mar'26",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2026 is 27.94% vs 9.30% in Mar 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2026 is 24.62% vs 4.16% in Mar 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "642.26",
          "val2": "502.00",
          "chgp": "27.94%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "221.91",
          "val2": "189.95",
          "chgp": "16.83%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "7.60",
          "val2": "5.85",
          "chgp": "29.91%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "172.89",
          "val2": "138.73",
          "chgp": "24.62%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "34.55%",
          "val2": "37.84%",
          "chgp": "-3.29%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Standalone) - Jun'26 - QoQstock-summary
Jun'26
Mar'26
Change(%)
Net Sales
105.68
80.17
31.82%
Operating Profit (PBDIT) excl Other Income
39.19
28.89
35.65%
Interest
1.76
1.97
-10.66%
Exceptional Items
0.00
0.00
Standalone Net Profit
33.83
25.77
31.28%
Operating Profit Margin (Excl OI)
37.08%
36.04%
1.04%
Values in Rs Cr.
Direction Arrows
Net Sales

QoQ Growth in quarter ended Jun 2026 is 31.82% vs -11.20% in Mar 2026

Direction Arrows
Standalone Net Profit

QoQ Growth in quarter ended Jun 2026 is 31.28% vs -4.09% in Mar 2026

Annual Results Snapshot (Consolidated) - Mar'26stock-summary
Mar'26
Mar'25
Change(%)
Net Sales
642.26
502.00
27.94%
Operating Profit (PBDIT) excl Other Income
221.91
189.95
16.83%
Interest
7.60
5.85
29.91%
Exceptional Items
0.00
0.00
Consolidate Net Profit
172.89
138.73
24.62%
Operating Profit Margin (Excl OI)
34.55%
37.84%
-3.29%
Values in Rs Cr.
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2026 is 27.94% vs 9.30% in Mar 2025

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Mar 2026 is 24.62% vs 4.16% in Mar 2025

stock-summaryCompany CV
About stock-summary
stock-summary
Company Coordinates stock-summary
Company Details
stock-summary
Tel:
stock-summary
stock-summary
Registrar Details